DBOAX
Price
$25.61
Change
-$0.09 (-0.35%)
Updated
Sep 12 closing price
Net Assets
287.44M
RLBBX
Price
$38.22
Change
-$0.06 (-0.16%)
Updated
Sep 12 closing price
Net Assets
262.26B
Interact to see
Advertisement

DBOAX vs RLBBX

Header iconDBOAX vs RLBBX Comparison
Open Charts DBOAX vs RLBBXBanner chart's image
BNY Mellon Balanced Opportunity A
Price$25.61
Change-$0.09 (-0.35%)
VolumeN/A
Net Assets287.44M
American Funds American Balanced R2
Price$38.22
Change-$0.06 (-0.16%)
VolumeN/A
Net Assets262.26B
DBOAX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DBOAX vs. RLBBX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBOAX is a StrongBuy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 262B vs. DBOAX (287M). RLBBX (1.15) and DBOAX (1.11) have matching dividends . DBOAX was incepted earlier than RLBBX: DBOAX (22 years) vs RLBBX (23 years). RLBBX (1.32) and DBOAX (1.26) have similar cost to investors . DBOAX (46.25) and RLBBX (44.00) have comparable annual turnover. RLBBX has a lower initial minimum investment than DBOAX: RLBBX (250) vs DBOAX (1000). RLBBX annual gain was more profitable for investors over the last year : 9.47 vs. DBOAX (5.92). RLBBX return over 5 years is better than : 38.77 vs. DBOAX (14.20).
DBOAXRLBBXDBOAX / RLBBX
Total Expense Ratio1.151.3287%
Annual Report Gross Expense Ratio1.261.3295%
Fund Existence22 years23 years-
Gain YTD9.02512.53272%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets287M262B0%
Annual Yield % from dividends1.111.1597%
Returns for 1 year5.929.4763%
Returns for 3 years24.3639.3062%
Returns for 5 years14.2038.7737%
Returns for 10 years29.3270.1642%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKDA3.48N/A
N/A
Arcadia Biosciences
ATRA12.12-0.04
-0.33%
Atara Biotherapeutics Inc.
SNX151.64-0.71
-0.47%
TD SYNNEX Corp
LION7.37-0.29
-3.79%
Lionsgate Studios Corp
EOLS7.19-0.32
-4.26%
Evolus